Given the current circulation of Zika virus,the evidence of an association between Zika virus infection during pregnancy and congenital malformations of the central nervous system (CNS),the association between Zikavirus infection and Guillain–Barré syndrome(GBS)and the risk of local vector-borne transmission in Europe during the 2016 summer season, EU/EEA Member States shouldconsider a range of mitigation measures.

Referenced at:

• Zika virus disease epidemic eight update

The spread of the Zika virus epidemic in the Americas is likely to continue as the competent vectors Aedes aegypti and Aedes albopictus mosquitoes are widely distributed there. There is also a significant increase in the number of babies born with microcephaly in the north-eastern states of Brazil, however, the magnitude and geographical spread of the increase have not yet been well characterised.

Referenced at:

• Zika virus disease epidemic: potential association with microcephaly and Guillain-Barré syndrome (first update)

Diese Gebührenverordnung findet Anwendung auf alle Anbringen, die ab dem 01.01.2016 beim BASG eingegangen sind.

Referenced at:

• Fees

From 1 January 2007 to23 March 2016, Zika virus transmission was documented in a total of 61 countries and territories.

Referenced at:

• ZIKA VIRUS MICROCEPHALY AND GUILLAIN-BARRÉ SYNDROME

product * Quality issues of the active substance * Regulatory changes Batch recall * Investigations at the manufacturer's related to GMP issues * Shortage of the active substance Prioritisation of supply [...] Delivery delay Delays during the release of the finished product Delays during the release of the active substance Constraints affecting packaging material availability Change of the marketing authorisation [...] product (please provide the information per authorised medicinal product and not on the package, active substance or indication level) Size of population affected by the shortage Market share Market sales

Referenced at:

• FAQ online Service
• Medicine shortages

Assessment of the Advisory Board on Classification regarding active+med Halstabletten Eukalyptus (German only)

Referenced at:

• Decisions of the AGBR

is therefore necessary not only to separate the activities in terms of space and organisation, but also to differentiate legally according to the activities performed. The public pharmacy and the pharmaceutical [...] entities, which act in different roles and on the basis of different laws, depending on their activities. Therefore, the company acts either as a public pharmacy or as a pharmaceutical wholesaler and

population by detecting and ending illegal activities on the basis of suspicious activity reports. However, particular attention is also paid to preventing illegal activities. Preventive measures are taken, for [...] investigated conscientiously. Help us to identify and eliminate health hazards! Report possible illegal activities related to drugs, blood and tissue products, medical devices or novel alternative therapies, either:

device. NOTE 1 “Deployment” is　synonymous with “activation”. A15 Activation Problem Problem associated with the activation of the device. A1501 Activation Failure Including Expansion Failures Problem associated [...] device failing to be activated including expansion. A150101 Difficult or Delayed Activation Problem associated with delayed or difficult activation of the device. A150102 Premature Activation Problem associated [...] associated with early and unexpected activation of the device. A150103 Self-Activation or Keying Problem associated with the unintended activation of the device, or the device having been unexpectedly turned

Referenced at:

• Medical devices vigilance